Schedule of Fair Value of Contingent Consideration Liability (Details) $ in Thousands	Sep. 30, 2023 USD ($)
Business Acquisition [Line Items]
Contractual Value	$ 6,000
Fair Value on the Merger Date	11,130
Milestone 1 [Member]
Business Acquisition [Line Items]
Contractual Value	1,500
Fair Value on the Merger Date	1,340
Milestone 2 [Member]
Business Acquisition [Line Items]
Contractual Value	3,000
Fair Value on the Merger Date	1,830
Milestone 3 [Member]
Business Acquisition [Line Items]
Contractual Value	1,500	[1]
Fair Value on the Merger Date	770	[1]
Royalty 1 [Member]
Business Acquisition [Line Items]
Fair Value on the Merger Date	5,980	[2]
Royalty 2 [Member]
Business Acquisition [Line Items]
Fair Value on the Merger Date	$ 1,210	[2]

[1] Indicates the maximum payable if the Milestone is achieved.

[2] As defined, Royalty Payments are based on a percentage of future revenues of DetermaIO and Pharma Services over their respective useful life, accordingly there is no fixed contractual value for the Royalty Contingent Consideration.